Anticoagulation Use and Clinical Outcomes After Major Bleeding on Dabigatran or Warfarin in Atrial Fibrillation | Zendy

Inmaculada Hernandez | Zendy; Yuting Zhang | Zendy; Maria M. Brooks | Zendy; Paul K. L. Chin | Zendy; Samir Saba | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Anticoagulation Use and Clinical Outcomes After Major Bleeding on Dabigatran or Warfarin in Atrial Fibrillation

Author(s) -

Inmaculada Hernandez,

Yuting Zhang,

Maria M. Brooks,

Paul K. L. Chin,

Samir Saba

Publication year - 2016

Publication title -

stroke

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.397

H-Index - 319

eISSN - 1524-4628

pISSN - 0039-2499

DOI - 10.1161/strokeaha.116.015150

Subject(s) - medicine , dabigatran , atrial fibrillation , warfarin , stroke (engine) , major bleeding , cardiology , intensive care medicine , mechanical engineering , engineering

Little is known about the clinical outcomes associated with posthemorrhage anticoagulation resumption for atrial fibrillation. This study had 2 objectives: first, to evaluate anticoagulation use after a first major bleed on warfarin or dabigatran and, second, to compare effectiveness and safety outcomes between patients discontinuing anticoagulation after a major bleed and patients restarting warfarin or dabigatran.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research